CKD Bio Corp.

KRX:063160.KS

29850 (KRW) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -24,192.52-16,702.616-6,576.6016,207.39812,264.887,956.1878,016.2999,434.6156,653.133-1,105.051,657.4497,101.2910,920.59614,375.71216,183.9298,737.629-3,273.392
Depreciation & Amortization 17,577.60117,938.25916,984.19512,235.2719,776.7978,955.5729,067.748,996.56610,904.4311,416.40211,712.59211,548.0869,398.6410,293.1466,036.2984,989.6965,491.21
Deferred Income Tax 00000000000000000
Stock Based Compensation 00000000000000000
Change In Working Capital -9,037.444-13,937.827-13,515.095-12,491.352-11,518.345-4,076.1544,230.704-4,186.352-7,061.457-61.487-3,648.2822,104.269-9,413.411-2,540.832,454.585-5,655.504-5,926.902
Accounts Receivables -8,440.947990.161-4,537.95417,307.603-12,566.418-2,533.1442,309.732174.594000000000
Inventory 3,426.655-13,183.224-10,810.83-26,870.572-3,099.7254,834.7745,157.99-3,747.714-4,547.8355,811.533-5,085.336-1,581.765-8,680.763933.2882,580.713-5,847.384-2,072.409
Accounts Payables -1,543.986-1,658.9992,116.831788.5911,256.432-3,939.7591,344.203515.967000000000
Other Working Capital -2,479.166-85.765-283.142-3,716.9742,891.366-8,910.928-927.286-438.638-2,513.622-5,873.021,437.0543,686.034-732.648-3,474.118-126.128191.88-3,854.493
Other Non Cash Items 8,428.4799,497.62-2,774.679-1,127.2976,466.9452,699.929-869.2181,255.1723,842.836973.0941,202.3312,146.4162,057.6461,759.4311,898.2162,617.2164,117.171
Operating Cash Flow -7,223.884-3,204.563-5,882.184,824.0216,990.27715,535.53420,445.52515,500.00114,338.94211,222.95910,924.0922,900.06112,963.47123,887.45926,573.02810,689.037408.087
Investing Activities:
Investments In Property Plant And Equipment -10,778.381-7,230.209-20,705.643-62,609.196-47,987.053-17,012.154-9,672.064-10,756.353-11,919.376-2,871.465-4,111.944-5,482.937-22,112.684-19,744.841-13,536.257-3,485.941-3,415.215
Acquisitions Net 17.88932.965219.63950.5-447.81615.909081.858.554001.4086.35113.9364,476.52865.19
Purchases Of Investments -777-13,349.27-374.7-235.5-1,388.15-271.9-4,044-432-432-552-552-336-588-519.22-552-542-1,335.999
Sales Maturities Of Investments 9,967.42-32.965649.5240.654,802.6731,047.0611,069.2250360002,30403.6513608.32,980
Other Investing Activites 374.50232.965-176.325-948.95672.751-519.5331,069.22581.8532.32747.79133.73642.882302.734-77.297-1,167.50539.87152.939
Investing Cash Flow -1,195.57-20,546.514-20,387.538-62,602.496-44,347.59-16,140.616-12,646.839-11,106.503-11,950.495-3,375.673-4,630.208-3,470.655-22,397.95-20,251.357-14,781.826496.758-1,653.085
Financing Activities:
Debt Repayment -8,083.43-36,695.228-44,547.055-78,409.486-8,188.155-5,907.005-44,866.919-34,143.514-1,817.071-7,346.606-11,304.72-3,670.905-3,189.651-10,701.68-16,736.913-17,360.386-21,845.464
Common Stock Issued 0004,452.88000000007,266.50000
Common Stock Repurchased 000-58.85700000000-897.006-743.472000
Dividends Paid 0-548.596-1,097.192-1,025.893-1,025.893-2,051.787-2,051.787-1,795.315-512.947-512.948-1,795.318-1,795.319-2,078.302-1,568.837-1,307.36700
Other Financing Activities 15,485.85162,203.10373,916.527129,794.31829,129.2174,832.35640,065.14936,079.131000005,40012,71013,16421,600
Financing Cash Flow 7,402.42124,959.27928,272.27954,752.96219,915.169-3,126.436-6,853.557140.302-2,330.018-7,859.554-13,100.038-5,466.2241,101.541-7,613.989-5,334.28-4,196.386-245.464
Other Information:
Effect Of Forex Changes On Cash -8.032-18.741-0.008-3.856-15.665-20.216-191.78611.31719.248-9.158-16.197-90.9627.1410.0010-0.0010.001
Net Change In Cash -1,025.0651,189.4612,002.552-3,029.369-7,457.809-3,751.735753.3424,545.11777.677-21.425-6,822.35313,872.221-8,325.797-3,977.8866,456.9226,989.408-1,490.461
Cash At End Of Period 3,630.2224,655.2873,465.8261,463.2744,492.64311,950.45315,702.18814,948.84610,403.72910,326.05210,347.47717,169.833,297.60911,623.40715,601.2939,144.3712,154.963